News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shire plc Release: Dermagraft® Now Available in Canada for the Treatment of Diabetic Foot Ulcers


3/25/2013 10:22:45 AM

MONTREAL, March 25, 2013 /CNW Telbec/ - Shire Canada Inc. announced today that DERMAGRAFT (human fibroblast-derived dermal substitute) is now available in Canada for the treatment of diabetic foot ulcers (DFUs) greater than 6 weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure.

Read at Canada NewsWire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES